Pharma-Bio Serv (PBSV) Amortization of Deferred Charges (2023 - 2026)
Pharma-Bio Serv (PBSV) posted Amortization of Deferred Charges of $29388.0 for Q1 2026, down 32.22% on a QoQ basis from $43359.0 in Q4 2025, and down 28.99% year-over-year from $41386.0 in Q1 2025.
Pharma-Bio Serv (PBSV) Amortization of Deferred Charges (2023 - 2026) Analysis & Trends
Pharma-Bio Serv's Amortization of Deferred Charges history runs 4 years deep, the most recent figure standing at $29388.0 for Q1 2026.
- Quarterly Amortization of Deferred Charges fell 28.99% year-over-year to $29388.0 in Q1 2026, while the trailing twelve-month figure through Apr 2026 was $115259.0 (down 29.6% YoY) and the FY2025 annual result came in at $169209.0, up 7.19% from the prior year.
- Amortization of Deferred Charges was $29388.0 for Q1 2026 at Pharma-Bio Serv, down from $43359.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $43359.0 in Q4 2025 and bottomed at $29388.0 in Q1 2026.
- A 4-year average of $38668.1 and a median of $39170.0 in 2024 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2025 — Amortization of Deferred Charges climbed 8.08% — and 2026, when it declined 28.99%.
- Pharma-Bio Serv's Amortization of Deferred Charges stood at $37553.0 in 2023, then grew by 8.08% to $40586.0 in 2024, then increased by 6.83% to $43359.0 in 2025, then plunged by 32.22% to $29388.0 in 2026.
- Business Quant data shows PBSV's Amortization of Deferred Charges at $29388.0 in Q1 2026, $43359.0 in Q4 2025, and $42512.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 31.61 Bn | 24.30 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 14.73 Bn | 13.83 Bn | 482.22 Mn |
| 3 | Healthequity | 8.26 Bn | 8.00 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.90 Bn | 5.58 Bn | 154.23 Mn |
| 5 | 10x Genomics | 5.90 Bn | 5.36 Bn | 106.18 Mn |
| 6 | MiniMed | 4.52 Bn | 4.22 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.42 Bn | 4.36 Bn | 216.84 Mn |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn |
| 9 | Privia Health | 3.17 Bn | 2.75 Bn | - |
| 10 | Pharma-Bio Serv | 13.28 Mn | 4.81 Mn | 902,041.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 29,388.00 |
| Jan 31, 2026 | 29,388.00 |
| Oct 31, 2025 | 43,359.00 |
| Oct 31, 2025 | 43,359.00 |
| Jul 31, 2025 | 42,512.00 |
| Jul 31, 2025 | 42,512.00 |
| Apr 30, 2025 | 41,952.00 |
| Apr 30, 2025 | 41,952.00 |
| Jan 31, 2025 | 41,386.00 |
| Jan 31, 2025 | 41,386.00 |
| Oct 31, 2024 | 40,586.00 |
| Oct 31, 2024 | 40,586.00 |
| Jul 31, 2024 | 39,806.00 |
| Jul 31, 2024 | 39,806.00 |
| Apr 30, 2024 | 39,170.00 |
| Apr 30, 2024 | 39,170.00 |
| Jan 31, 2024 | 38,291.00 |
| Jan 31, 2024 | 38,291.00 |
| Oct 31, 2023 | 37,553.00 |
| Oct 31, 2023 | 37,553.00 |